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Specific Synergy of Multiple Substrate±Receptor
Interactions in Platelet Thrombus
Formation under Flow
IV (CD-36) (Diaz-Ricart et al., 1993), and a fourth receptor
recently cloned (Chiang et al., 1997). The functional inte-
gration of the distinct adhesion pathways involved in
the initiation of platelet thrombus formation has not yet
been defined. To address this issue, we have studied
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The Scripps Research Institute three-dimensional measurements of surface coverage
in real time. Our results demonstrate that the initial GPLa Jolla, California 92037
Iba±mediated function of vWF leadsto irreversible plate-
let adhesion and aggregation in concert with specific
activities of a2b1 and aIIbb3. These synergistic interactionsSummary
support thrombus development responding to varia-
tions in substrate composition and hemodynamic con-Wehave used confocal videomicroscopy in real time to
ditions.delineate theadhesive interactions supporting platelet
thrombus formation on biologically relevant surfaces.
Type I collagen fibrils exposed to flowing blood adsorb Results
von Willebrand factor (vWF), to which platelets be-
come initially tethered with continuous surface trans- Role of Plasma vWF and Platelet GP Iba in Concert
location mediated by the membrane glycoprotein Iba. with Integrins aIIbb3 and a2b1 in Thrombus
This step is essential at high wall shear rates to allow Formation on Type I Collagen Fibrils
subsequent irreversible adhesion and thrombus growth Platelets adhered firmly to type I collagen fibrils at wall
mediated by the integrins a2b1 and aIIbb3. On subendo- shear rates between 100 and 1500 s21, forming thrombi
thelial matrix, endogenous vWF and adsorbed plasma whose number and growth rate depended on thevolume
vWF synergistically initiate platelet recruitment, and of blood perfused per unit of time (Figure 1). Inhibition
a2b1 remains key along with aIIbb3 for normal thrombus of aIIbb3 permitted stable single platelet adhesion but
development at all but low shear rates. Thus, hemo- abolished thrombus growth at all shear rates. In con-
dynamic forces and substrate characteristics define trast, inhibition of plasma vWF A3 domain binding to
the platelet adhesion pathways leading to thrombo- collagen obliterated all initial platelet surface interac-
genesis. tions at 1500 s21, but had no effect on thrombus forma-
tion at 500 s21 or lower shear rates (Figure 1). Blockade
of GP Iba abolished platelet deposition at 1500 s21 and
Introduction caused a partial but significant (p , 0.01) reduction of
thrombus volume at 500 s21, but had no effect (p . 0.1)
Platelets adhere and aggregate at sites of vascular injury at 100 s21 (Figure 1). The specificity of inhibition by
contributing to the arrest of bleeding but also to the monoclonal antibodies was demonstrated with four dis-
pathologic occlusion of diseased vessels. At shear rates tinct isotype-matched IgGs against different epitopes
equivalent to those generated by blood flow in normal in vWF, GP Iba, and the integrin b3 subunit. All control
arterioles (Tangelder et al., 1988) or in stenotic arteries antibodies allowed thrombus formation with mean vol-
(Back et al., 1977), adhesion requires von Willebrand ume within 617% of that obtained with untreated blood.
factor (vWF) (Sakariassen et al., 1979) present as endog- The total volume of thrombi formed aftera 3 min perfu-
enous subendothelial matrix component (Sporn et al., sion at 1500 s21 was lower on surfaces prepared with
1989) or adsorbed onto tissues exposed to plasma (Par- collagen coating concentration of 0.01, as compared to
eti et al., 1987). The membrane glycoprotein (GP) Iba can 0.1 or2.5 mg/ml, but thrombus height remained constant
tether platelets to immobilized vWF A1domain opposing (Figure 2A). Thus, differences in total volume appear to
elevated shear forces, but alone cannot support perma- result from changes in the number rather than size of
nent attachment, owing to a high dissociation rate. This individual thrombi, reflecting fibril density more than the
interaction, therefore, results in platelet translocation on degree of platelet activation. Blockade of a2b1 with a
reactive surfaces, but at greatly reduced velocity relative monoclonal antibody caused greater than 50% inhibi-
to free flow, a step instrumental in the formation of addi- tion of total thrombus volume, as well as decreased
tional bonds that eventually mediate stable adhesion height, albeit only on surfaces with low collagen concen-
and aggregation (Savage et al., 1996). Collagen, particu- tration (Figure 2A), suggesting an influence on both size
larly types I, III, and VI, present in different layers of the and number of individually growing thrombi. No effect
vessel wall is likely to play a key role in the latter process was seen with a control antibody against a different
(Baumgartner et al., 1977) by binding to different platelet epitope in a2b1. We then evaluated whether the receptor
membrane glycoproteins. These include a2b1 (GP Ia-IIa) participates in platelet adhesion preceding thrombus
(Nieuwenhuis et al., 1985), GP VI (Moroi et al., 1996), GP growth by measuring surface coverage at 10 s intervals
from the onset of flow at the wall shear rate of 1500 s21.
Blocking a2b1 was inconsequential when the collagen*To whom correspondence should be addressed.
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thrombus volume when the wall shear rate was 500 s21,
with significant reduction (p , 0.05) seen only at the
coating concentration of 0.01 mg/ml (Figure 2B); inhibi-
tion was even less at 100 s21 (Figure 2C). The function
of a2b1, therefore, acquires relevance for adhesion and
thrombus formation when platelets are subjected to in-
creasing hemodynamic drag on surfaces with relatively
sparse collagen fibrils.
Integrins a2b1 and aIIbb3 Mediate Platelet
Adhesion to Type I Collagen Fibrils
with Bound vWF
Stable platelet attachment to a reactive surface is the
essential first step in thrombus development. The mech-
anism responsible for this process was analyzed at the
wall shear rate of 1500 s21 in order to model the hemody-
namic challenge to adhesion that may exist in arterioles
(Tangelder et al., 1988) where platelets are essential for
hemostasis. Chelation of divalent cations in blood by
EDTA allowed tethering and continuous translocation of
platelets but prevented irreversible adhesion to collagen
type I fibrils, indicating the involvement of integrin±
ligand interactions in the latter event (Figure 3A). Platelet
displacement exhibited similar characteristics on colla-
gen as on glass coated with purified vWF or collagen
saturated with vWF before perfusion (Figure 3A), sug-
gesting that adsorption of plasma vWF by type I collagen
fibrils, like GP Iba±mediated platelet tethering, is inde-
pendent of divalent cations. As shown in Figure 1, trans-
location on collagen was prevented by blocking GP Iba
(Savage et al., 1996) as well as the plasma vWF A3
domain, confirming the indispensable role of immobi-
lized vWF in establishing platelet surface contacts.Figure 1. Plasma vWF, GP Iba, and aIIbb3 Participate in Platelet
The nature of the bonds involved in the transitionThrombus Formation on Type I Collagen Fibrils
from initial tethering to irreversible platelet adhesion wasBlood containing 80 mm PPACK as anticoagulant and treated with
the fluorescent dye mepacrine for platelet visualization was per- probed using function-blocking monoclonal antibodies
fused in a parallel plate chamber at 378C over glass coverslips against aIIbb3 and a2b1. Aggregate formation and throm-
coated with 2.5 mg/ml of fibrillar type I collagen. Flow was set to bus growth were abolished by inhibiting aIIbb3, thus
produce wall shear rates of 100, 500, or 1500 s21, and each experi-
allowing direct evaluation of individual platelet interac-ment was recorded on tape using a videomicroscopy system. The
tions with the substrate. Under these conditions, thefigure shows single frame images of the surface, each correspond-
collagen surface became rapidly covered with firmlying to an area of 65,536 mm2, after 2 min of perfusion at each indi-
cated wall shear rate. Blood was either untreated or treated with adherent platelets, and approximately 60% of first con-
monoclonal antibodies selectively inhibiting the binding of plasma tact events resulted in prolonged adhesion with no
vWF to collagen or the ligand-binding function of the platelet recep- translocation from the initial point of tethering (Figure
tors GP Iba and aIIbb3. Note that inhibiting GP Iba or plasma vWF 3B). However, when aIIbb3 and a2b1 were blocked concur-binding to collagen essentially abolished all platelet±surface interac-
rently, approximately 90% of the platelets becomingtions at 1500 s21 (only brief contact events occurred with no surface
tethered to the surface moved to a position differenttranslocation) but had limited or no effects at the lower wall shear
rates. These images are representative of the results obtained in from the point of first contact within 4 s (Figure 3B). This
six separate experiments with blood from different donors. After 2 behavior is akin to that previously reported for platelets
min perfusion, the total volume of platelet thrombi present on a interacting with vWF immobilized onto glass (Savage et
surface of 102,236 mm2 was measured by confocal sectioning at
al., 1996). Similar results were obtained when platelet1.0 mm intervals, as described in Experimental Procedures. Volume
activation was inhibited with prostaglandin E1 and a2b1measurements represent the mean 6 SEM of four separate experi-
function was simultaneously blocked (data not shown).ments with different blood donors. The size of single platelets can
be appreciated in the panels showing the results obtained in the The average velocity of platelets translocating on the
presence of the anti-aIIbb3 antibody. collagen±vWF surface under these conditions was 5.5
mm/s (Figure 3B), similar to that measured at the same
shear rate of 1500 s21 on purified vWF bound to glass
(Savage et al., 1996).coating concentration was 2.5 mg/ml but caused a re-
duction in surface coverage before the appearance of The time course required to establish bonds support-
ing stable platelet adhesion was evaluated from the on-aggregates at the coating concentration of 0.1 mg/ml
(Figure 2A), indicating a role in initial platelet attachment. set of flow. After 8 s of perfusion, greater than 95% of
platelets interacting with the surface were displacedIn contrast, blocking a2b1 had modest effects on total
Mechanisms of Platelet Thrombus Formation
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Figure 2. Role of a2b1 in Platelet Adhesion
and Thrombus Formation on Surfaces Coated
with Different Densities of Type I Collagen
Fibrils
The collagen concentration used for surface
coating was 2.5, 0.1, or 0.01 mg/ml, as indi-
cated. Blood, either untreated (dark bars) or
after selective inhibition of a2b1 with a mono-
clonal antibody (light bars), was perfused
over the different collagen-coated surfaces
in a parallel plate chamber as described in
the legend to Figure 1. Single frame images,
each corresponding to an area of 65,536 mm2
and representative of different tested condi-
tions after 2 min perfusion, are shown on the
right. After 2 min perfusion, the total volume
occupied by platelet thrombi in an area of
102,236 mm2 was measured by confocal sec-
tioning at 1.0 mm intervals (see Experimental
Procedures).
(A) Experiments performed at wall shear rate
of 1500 s21. Maximum thrombus height was
estimated from series of confocal sections as
the distance between the collagen surface
and the tip of the highest thrombus in the
area. The two bar graphs on the right show
the effect of blocking a2b1 function on the
time course of platelet adhesion to surfaces
coated with the two indicated concentrations
of fibrillar type I collagen (open bars, a2b1
blocked; filled bars, untreated blood). Images
were captured from videotape at 10 s inter-
vals after the onset of blood flow, and the
total surface coverage by platelets in an area
of 65,536 mm2 was measured as described in
Experimental Procedures.
(B) Experiments performed at wall shear rate
of 500 s21.
(C) Experiments performed at wall shear rate
of 100 s21.
from the point of initial contact within 5 s when a2b1 was through bonds rapidly established by a2b1 following the
initial tethering of GP Iba to collagen-bound vWF. Theblocked in addition to aIIbb3, as compared to approxi-
mately 60% when only aIIbb3 function was inhibited. After stable number of this population may indicate saturation
of all the collagen sites capable of interacting with a2b1.1 or 2 min of perfusion, approximately 90% of platelets
were displaced from the point of initial tethering within Platelets that were translocating when aIIbb3 function
was inhibited represent the ones that may become irre-10 s when a2b1 and aIIbb3 were blocked concurrently, as
opposed to less than 40% when only aIIbb3 function was versibly attached when the latter receptor can interact
with the Arg-Gly-Asp sequence in collagen-bound vWF,inhibited (Figure 4). Differences in the stability of adhe-
sion were reflected in the total number of platelets on the a previously proven pathway of adhesion to purified
vWF immobilized onto glass (Savage et al., 1996). Alter-surface, peaking after about 1 min, and almost doubling
natively, or in addition, other aIIbb3 ligands such as fibrin-when aIIbb3 was blocked selectively as compared to
ogen, fibronectin, or vitronectin (Plow et al., 1985; Thia-when a2b1 and aIIbb3 were blocked concurrently (Figure
garajan and Kelly, 1988) may be adsorbed from plasma4). The platelet displacement profiles and total number
or released locally by activated platelets, thus contribut-of platelets on the surface were essentially identical
ing to stabilizing adhesion.between 1 and 2 min, indicating the lack of changes in
either platelet or surface reactivity with time. When only
aIIbb3 was inhibited, approximately 70% of platelets were Platelet Adhesion and Thrombus Formation on
Subendothelial Matrix Require Endogenousfirmly attached after 2 min; the remaining 30% were
transiently interacting but continuously exchanged ev- as Well as Plasma vWF, a2b1, and aIIbb3
The mechanism supporting thrombus growth on type Iery 5 s, as reflected by the constant number of platelets
on the surface (Figure 5). Under these conditions, there- collagen fibrils was confirmed by studies with subendo-
thelial extracellular matrix. The function of GP Iba wasfore, the majority of platelets were irreversibly adherent
Cell
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Figure 4. Time Course of the Transition from Initial Platelet Teth-
ering with Translocation to Irreversible Adhesion Mediated by a2b1
and aIIbb3 on a Collagen-Coated Surface
Blood was perfused at a wall shear rate of 1500 s21 over surfaces
prepared with a collagen coating concentration of 0.1 mg/ml. Plate-
let aIIbb3 function was blocked either selectively (open circles) or
concurrently with inhibition of a2b1 (filled circles) using specific
monoclonal antibodies. Consecutive images were captured from
videotapes and analyzed for the total number of platelets on the
surface, as well as for platelet movement (for definition, see Experi-
mental Procedures) at 8 s (left panels), 60 s (middle panels), and
120 s (right panels) after the onset of blood flow. Note that blocking
both receptors simultaneously resulted in the displacement of
greater than 80% of platelets within 10 s from the initial tethering
at all time points. In contrast, up to 60% of the total platelets on
the surface remained firmly attached in the same position after 2
Figure 3. Integrins a2b1 and aIIbb3 Contribute to Stabilize the Adhe- min perfusion when only aIIbb3 function was blocked.
sion of Platelets Initially Tethered to Collagen-Bound vWF
(A) Blood containing 5 mM EDTA to inhibit the function of platelet
was dependent on the availability of divalent cations.integrins was perfused at the wall shear rate of 1500 s21 over a
Selective inhibition of aIIbb3 allowed firm adhesion ofsurface coated with either fibrillar type I collagen (left panel; coating
approximately 50% of the platelets initially tethered toconcentration of 2.5 mg/ml), purified vWF (middle panel; coating
the matrix (Figure 6), a value similar to that seen onconcentration of 0.1 mg/ml), or collagen preincubated with purified
vWF before the onset of blood flow (right panel). After 2 min perfu- fibrillar type I collagen (Figure 3B). In contrast, approxi-
sion, consecutive images were captured from videotapes and ana- mately 30% of initially tethered platelets still became
lyzed for platelet movement (for definition, see Experimental Proce- firmly adherent for at least 10 s when aIIbb3 and a2b1dures). A single frame image corresponding to an area of 65,536
were inhibited concurrently (Figure 6), thus more than
mm2 is shown for each condition tested. The percentage of platelets
the 10% seen on type I collagen fibrils (Figure 3B). Thisdisplaced from their initial position was calculated as a function of
value was reduced by blocking the integrin subunit a5,time relative to the total number of platelets attached to the surface
indicating a possible contribution of matrix or plasmain the first imageanalyzed. Note that greater than 90% of all platelets
moved on the surface within 3 s of observation, indicative of pre- fibronectins to the stabilization of platelet interaction
dominantly transient attachment with surface translocation medi- with the subendothelium (Figure 6).
ated by GP Iba interaction with surface-bound vWF. In spite of the The volume of thrombi formed on the matrix at shear
movement, most of the platelets remained persistently tethered to
rate of 1500 s21 was similar to that on type I collagenthe surface.
fibrils (compare Figure 7 with Figures 1 and 2) and was(B) Perfusion over collagen-coated surfaces of blood containing 80
reduced 80% or more by blocking selectively either a2b1mm PPACK as anticoagulant and the function-blocking monoclonal
on platelets or the A1 domain of subendothelial vWF orantibodies of indicated specificity. The stability of platelet adhesion
was evaluated after 2 min perfusion. Note that approximately 90% of the A3 domain of vWF in perfused blood (Figure 7).
all platelets (indicated as platelets displaced) moved on the surface Thrombi formed on the matrix at 500 s21 were larger
within 3 s of observation when aIIbb3 and a2b1 were inhibited concur- than at 1500 s21 and twice as large as on collagen,
rently, as opposed to greater than 60% of the platelets remaining whereas at 100 s21 they were about the same size on
stationary (40% displaced) after selective inhibition of aIIbb3. The both substrates and smaller than at higher shear ratesfrequency distribution of the average velocity of individual platelets
(compare Figure 7 with Figures 1 and 2). The anti-a2b1with blocked aIIbb3 and a2b1 moving on the surface is also shown.
and anti-vWF antibodies decreased the total volume ofThe two single frame images on the right, each representing an area
thrombi deposited on the matrix by more than 60%of 65,536 mm2, depict surface coverage after 2 min perfusion of
platelets with selective aIIbb3 inhibition (top) or combined aIIbb3 and at 500 s21 but had no effect at 100 s21 (Figure 7). As
a2b1 inhibition. anticipated, blocking aIIbb3 abolished thrombus forma-
tion at all shear rates (not shown).
essential for initiating platelet recruitment on this sub- Discussion
strate when blood was perfused at the wall shear rate
of 1500 s21 (Figure 6), and stable attachment, but not We have used real-time analysis of platelet±substrate
interactions and volumetric measurements by confocalcontinuous translocation, of surface-tethered platelets
Mechanisms of Platelet Thrombus Formation
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Figure 5. Stability of Platelet Attachment to Collagen after Blocking
Platelet aIIbb3 Function
Blood with added anti-aIIbb3 monoclonal antibody was perfused at
a wall shear rate of 1500 s21 over surfaces prepared with a collagen
coating concentration of 0.1 mg/ml. Consecutive images were cap-
tured from videotape beginning 120 s after the onset of flow and
analyzed for the total number of platelets on the surface and for
Figure 6. Mechanism of Initial Platelet Tethering and Stable Adhe-platelet movement (for definition, see Experimental Procedures).
sion to Extracellular Matrix Deposited by Endothelial CellsLeft panels (open circles), total number of platelets (upper) and
Blood for these experiments, prepared as described in the legenddisplaced platelets (lower) considering all those on the surface.
to Figure 1, was perfused over extracellular matrix (see ExperimentalRight panels (filled circles), total number of platelets not firmly
Procedures) at the wall shear rate of 1500 s21.attached (upper) and time course of their displacement (lower) after
(Top) Surface coverage over an area of 65,536 mm2 observed duringexcluding stationary platelets by image processing.
perfusion of blood without (Control) or with addition of a function-
blocking anti-GP Iba monoclonal antibody. Measurements represent
the mean 6 SEM of six determinations on different areas. Surface
videomicroscopy to illustrate a paradigmatic mecha- coverage was inhibited greater than 95% by blocking GP Iba.
nism of thrombogenesis. The same sequence of events (Bottom) Motion analysis of platelets interacting with the surface
appears to take place when blood flowing with arteriolar during perfusion of blood containing EDTA (see Figure 2) or the
function-blocking monoclonal antibodies of indicated specificity.wall shear rate is exposed to type I collagen fibrils or
Consecutive images were captured from videotapes and analyzedsubendothelial matrix. In either case, initial platelet teth-
for platelet movement (for definition, see Experimental Procedures).ering mediated by immobilized vWF and GP Iba leads to
integrin-dependent irreversible adhesion and thrombus
growth (see Table 1). The importance of specific interac- (Tangelder et al., 1988), binding of plasma vWF to colla-
gen or extracellular matrix and subsequent GP Iba bind-tions in these processes may vary, depending on hemo-
dynamic parameters. For example, vWF and integrin ing to immobilized vWF is required for initial platelet±
surface contact. As previously discussed, the lattera2b1 are not required at lower shear rates, but their key
function at the higher shear rates relevant to hemostasis process depends on bonds that form with fast forward
rate but support slow translocation rather than arrest atand thrombosis has now been identified.
In agreement with a previously proposed hypothesis, the site of first contact because of an inherently short
half-life (Savage et al., 1996). Nevertheless, coupling ofit is apparent that substrate-bound vWF, like purified
vWF immobilized onto glass (Savage et al., 1996), is GP Iba to the vWF A1 domain substantially reduces the
velocity of tethered platelets compared to those flowinguniquely efficient in tethering rapidly flowing platelets
to an exposed thrombogenic surface. At shear rates freely in the boundary layer, enabling interactions that
have relatively slow forward rates but are required forwithin the range of arteriolar flow, such as 1500 s21
Table 1. Interactions Proposed to Partici-
pate in Mediating Platelet Adhesion and In-
ducing Aggregation on Subendothelial Matrix
and Collagen Fibrils at High Shear Rate
The events depicted here in temporal se-
quence from left to right, initiating with plate-
let tethering to a reactive surface, are pro-
posed to be involved in thrombogenesis at
arteriolar wallshear rates (1500 s21), but some
may not be relevant at lower shear rates. The
scheme considers only adhesive interactions
whose role has been defined in these studies and does not exclude the relevance of other ligand±receptor pairs for platelet thrombus formation,
nor the role of other agonists in platelet activation. The two arrows of different weight connecting activation and stable adhesion express the
hypothesis that activation may in general precede stable adhesion but the latter may contribute to enhance activation. ECM denotes an
interaction that may occur on endothelial cell matrix but is not proven to occur on collagen fibrils.
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of endogenous vWF and the availability of vWF-binding
sites are limiting, such that additional binding of plasma
vWF can complement the function of the endogenous
protein, but neither is sufficient independently. Alterna-
tively, the vWF A1 and A3 domains may have yet unde-
fined properties, in addition to promoting initial platelet
tethering, that render them indispensable for thrombus
development at higher shear rates. Such properties may
be influencedby thesubstrate onto which vWF becomes
immobilized, which in the case of subendothelial matrix
may be collagen type VI (Rand et al., 1991) as well as
a noncollagenous component (Wagner et al., 1984). Of
note in this regard, thrombus formation has been shown
to vary under flow conditions, depending on whether
vWF is bound to collagen type I (Alevriadou et al., 1993)
or VI (Ross et al., 1995).
At shear rates relevant for hemostasis in arterioles
(Tangelder et al., 1988), as well as thrombosis in athero-
sclerotic arteries (Back et al., 1977), a2b1 and aIIbb3 are
prominent in mediating stable platelet adhesion and ag-
gregation. Therole of aIIbb3 as a key receptor for adhesive
proteins, notably fibrinogen and vWF (Ikeda et al., 1991),
that are involved in linking platelets to one another is
well established (Phillips et al., 1991). Our findings now
define a unique function for a2b1 among collagen recep-
tors, expressed by its ability to act in concert with GP
Iba±vWF and aIIbb3 to promote stable platelet adhesion
as well as activation. It is apparent from the experiments
on subendothelial matrix that both attributes are impor-
tant, since selective a2b1 blockade caused a relatively
modest inhibition of surface coverage but a pronounced
Figure 7. Mechanism of Platelet ThrombusFormation on Extracellu- decrease in thrombus volume (compare Figures 6 and
lar Matrix Deposited by Endothelial Cells 7) (Keely and Parise, 1996). Such an effect on the forma-
The blood used for these perfusion studies contained 80 mm PPACK tion of large aggregates cannot depend on direct partici-
as anticoagulant, without (Control) or with addition of the function- pation in interplatelet bonding. Rather, it may reflect the
blocking monoclonal antibodies of indicated specificity (anti-a2b1 or
role of a2b1 in platelet activation following adhesion, aanti-vWF A3 domain); the experiment labeled ªanti-vWF A1 Domainº
function possibly crucial when thrombin activity is lim-was performed by perfusing control blood over subendothelial ma-
trix previously saturatedwith monovalent Fab fragment of the mono- ited, as in our experimental model. Indeed, these find-
clonal antibody NMC-4 (see Experimental Procedures). The total ings provide a mechanistic explanation for the occur-
volume of platelet thrombi present on a surface of 102,236 mm2 was rence of bleeding in patients with congenital defects of
measured by confocal sectioning at 1.0 mm intervals, as described
a2b1 (Nieuwenhuis et al., 1985).in Experimental Procedures, during perfusion at the three indicated
Subendothelial matrix and collagen fibrils synthesizedwall shear rates. The single frame images shown on the right, each
by other cells in the vessel wall are both likely to becorresponding to an area of 65,536 mm2, exemplify the inhibition of
platelet thrombus development on subendothelial matrix by the anti- involved in thrombogenesis, perhaps with greater rele-
a2b1 monoclonal antibody. vance of the former in vascular disease and of the latter
upon blood contact with extravascular tissues after
trauma. Compared to isolated collagen fibrils, subendo-
irreversible adhesion (Savage et al., 1996). Of note, GP thelial matrix contains other components that may par-
Iba±mediated tethering resulted in similar velocity of ticipate in establishing adhesive interactions, for exam-
translocation whether vWF was immobilized onto glass, ple, fibronectin, which can bind to a5b1 on platelets
adsorbed onto collagen under static conditions, or (Ginsberg et al., 1993) (Figure 6). With respect to colla-
bound from plasmaunder flow conditions. This observa- gen, however, a2b1 and aIIbb3 seem to provide essentially
tion indicates that the affinity of vWF for GP Iba is regu- all the bonds required to mediate platelet adhesion
lated by intrinsic properties of the immobilized A1 do- against elevated shear stress, albeit with the necessary
main and not by conformational changes specifically contribution of adsorbed plasma proteins, among which
induced upon binding to collagen or other matrix com- vWF is notable. The surface density of collagen may
ponents, a commonly stated hypothesis never proven modulate these events to the extent that, when it is
experimentally. sufficiently high, aIIbb3 alone may stabilize the attach-
It was surprising to find that both the A3 domain of ment of enough platelets to initiate rapid thrombus for-
plasma vWF and the A1 domain of endogenous suben- mation without involving a2b1. This function of aIIbb3 has
dothelial vWF were needed concurrently to initiate plate- been documented to occur with purified vWF immobi-
let tethering and thrombus formation on matrix exposed lized onto nonbiological surfaces when the receptor pro-
motes platelet arrest by interacting with the Arg-Gly-Aspto high shear rate (Figure 7). Possibly both the amount
Mechanisms of Platelet Thrombus Formation
663
The glass slides covered by endothelial cell monolayers were as-sequence in the vWF C1 domain, following activation
sembled as the base of rectangular parallel plate perfusion cham-induced by initial GP Iba tethering to the A1 domain
bers used to expose cells to laminar flow, according to a previously(Savage and Ruggeri, 1991; Savage et al., 1996). A simi-
published method (Frangos et al., 1985) with minor modifications.
lar process may occur when plasma vWF is immobilized A shear stress of 14 dynes/cm2 was applied for 4±6 hr, followed by
onto collagen fibrils. Consequently, the need for a2b1 58 dynes/cm2 for an additional 15 hr. The glass slides were then
removed from the chamber, and the cells were detached by incuba-may be bypassed at higher collagen density because
tion for 3 min at 378C with 20 mM NH4OH and 0.5% Triton X-100 inincreased amounts of bound vWF may enhance signal
phosphate-buffered saline. The matrix remaining attached to thetransduction through GP Iba, potentiating the synergism
glass slides was washed repeatedly with phosphate-buffered salinewith other receptors and inducing aIIbb3 function. In this (Gospodarowicz et al., 1981) and used immediately in blood perfu-
regard, platelets may be activated following GP Iba oc- sion studies.
cupancy by vWF (De Marco et al., 1985; Du et al., 1994),
as well as collagen interaction with GP VI (Ichinohe et Functional Inhibition of Platelet Receptors and vWF Domains
All the murine monoclonal antibodies used in these experimentsal., 1997) and the 65 kDa receptor (Chiang et al., 1997),
were obtained and characterized as previously described. Theyin addition to a2b1 (Polanowska-Grabowska et al., 1993;
were purified using protein A (Sigma) chromatography according toKeely and Parise, 1996). Moreover, other adhesive pro-
published procedures (Ey et al., 1978). LJ-Ib1 (IgG1) reacts with theteins present in blood and known to be aIIbb3 ligands, amino-terminal 45 kDa domain of GP Iba containing the vWF binding
for example, fibronectin (Plow et al., 1984), may interact site (Handa et al., 1986; Vicente et al., 1988, 1990) and inhibits
with collagen and provide the substrate for irreversible completely this interaction under all experimental conditions tested
(Alevriadou et al., 1993). The binding of this antibody to platelets isplatelet adhesion after initial tethering to the vWF A1
specifically abolished by the Ala156→Val mutation described in adomain. A composite of all these events may also take
patient with Bernard-Soulier syndrome (Ware et al., 1993). LJ-CP8place on subendothelial matrix where, however, the
(IgG1) reacts with the integrin aIIbb3 (GP IIb-IIIa complex) and blocksfunction of a2b1 may remain indispensable, perhaps re- the activation-dependent binding of soluble ligands to this receptor
flecting a relatively limiting concentration of exposed (Niiya et al., 1987; Weiss et al., 1989) as well as platelet aggregation
collagen. and thrombus formation under all experimental conditions tested
(Weiss et al., 1989). This antibody also inhibits platelet adhesion toOur studies indicate that the adhesive potential of
immobilized fibrinogen (Savage et al., 1992, 1996) and irreversibleplatelets results from the sum of distinct pathways sup-
single platelet attachment to immobilized vWF (Savage et al., 1996).ported by coordinated receptor±ligand interactions spe-
NMC-4 reacts with the A1 domain of vWF (Fujimura et al., 1991) andcifically adapted to respond to different environmental
blocks all its functions, in particular vWF interaction with GP Iba
conditions. This may be a relevant paradigm to interpret (Mohri et al., 1989). The epitope recognized by this antibody has
the multiplicity of adhesion mechanisms in other cells. been defined at the atomic level (Celikel et al., 1998). MR-5 (IgG1)
reacts with a distinct sequence (residues 948±998) in the A3 domainSuch variables as the composition of a reactive surface
of vWF (Roth et al., 1986) and blocks the interaction between vWFand hemodynamic forces may directlymodulate the pro-
and collagen under all experimental conditions tested (Roth et al.,cess of adhesion and ensuing activation, affecting the
1986; Pareti et al., 1987). Antibody R2±7E4 (IgG1) was obtained fromrate of thrombus growth and determining the outcome
the same fusion as the previously reported antibody R2±8C8 (Diaz-
of the hemostatic response or the occurrence of patho- Gonzalez et al., 1996); as the latter, it exhibits recognition specificity
logical thrombosis. In all these instances, functional in- for the a2 subunit of integrin a2b1 and inhibits the adhesion of Chi-
nese Hamster ovary cells transfected with a2b1 to type I collagen integration of the platelet receptors GP Iba, a2b1, and aIIbb3
the absence of shear. Antibody 12F1 (IgG2a) binds to platelet a2b1with their respective ligands now appears to have direct
but does not inhibit interactions with collagen (Pischel et al., 1988).physiopathological relevance.
Antibody MAb16 reacts with the a5 subunit of integrin a5b1 and
inhibits interaction with fibronectin, as previously reported (Akiyama
et al., 1989; Yamada et al., 1990). The murine monoclonal antibodiesExperimental Procedures
used as additional isotype-matched controls have been previously
characterized: LJ-Iba1 is an anti-GP Iba IgG1 (Ware et al., 1993);Preparation of Collagen-Coated Coverslips
LJ-Ib10, an anti-GP Iba IgG2a (Handa et al., 1986); LJ-2.2.9, an anti-Suspensions of acid-insoluble fibrillar type I collagen from bovine
vWF IgG1 (Schneppenheim et al., 1996); and AV-10, an anti-b3 IgG1Achilles tendon (Sigma) in 0.5 M acetic acid (pH 2.8) were prepared
(Felding-Habermann et al., 1996). Monovalent Fab fragments of anti-as previously described (Folie et al., 1988). Two hundred microliters
bodies NMC-4 and MR-5 were prepared according to a publishedwas applied evenly over horizontal glass coverslips (Corning, Inc.;
method (Celikel et al., 1997) and used to block the A1 and/or A324 mm 3 50 mm) that were then placed in a humid environment at
domain of immobilized vWF; blockade of the same domains of solu-room temperature (228C±258C) for 60 min. After removing excess
ble vWF could be achieved with identical results using intact IgG.collagen by four sequential rinses with phosphate-buffered saline
All antibodies, except NMC-4, were used at a final concentration of(PBS) (pH 7.4), a coverslip was assembled in the flow chamber.
100 mg/ml in blood, shown to produce their maximal specific effect.Saturating the surface with bovine serum albumin (0.1 mg/ml) did
A solution of NMC-4 Fab at the concentration of 100 mg/ml wasnot affect initial platelet adhesion or subsequent thrombus forma-
evenly distributed over the extracellular matrix for 20 min at roomtion, and uncoated coverslips did not support platelet adhesion
temperature. The substrate was then washed extensively before(unpublished observations).
use in the blood flow experiments.
Perfusion Chamber and Epifluorescence VideomicroscopyPreparation of Coverslips Coated with Extracellular
Matrix Deposited by Endothelial Cells Platelet interaction with immobilized collagen under various flow
conditions was studied using a modification of a Hele-Shaw flowHuman umbilical vein endothelial cells were purchased and cultured
in growth medium (Clonetics Corp., San Diego, CA). After reaching chamber described elsewhere (Usami et al., 1993; Savage et al.,
1996). Collagen-coated coverslips formed the lower surface of theconfluence in T-75 tissue culture flasks, endothelial cells always
before passage three were seeded and cultured on sterile 25 mm chamber, and a flow path height of 254 mm was determined by a
silicone rubber gasket. The flow chamber was assembled and filledglass slides (Corning Glass, Vineland, NJ). The cells were grown on
the slides for 1±3 days to reach confluence and then maintained for with PBS (pH 7.4). A syringe pump (Harvard Apparatus Inc.) was
used to aspirate blood through the flow chamber. Flow rates ofan additional 1±2 days in a humidified 5% CO2 incubator at 378C.
Cell
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1.94, 0.65, and 0.13 ml/min produced initial wall shear rates of 1500 nm and a scanning time of 2 s per section. The microscope set-
tingsÐincluding contrast, brightness, magnification, and pinholes21, 500 s21, and 100 s21, respectively,at the inletof the flow chamber
where all measurements of platelet adhesion and thrombus forma- apertureÐwere maintained constant in order to facilitate compari-
sons between different experiments. Confocal sections were ana-tion were made. Blood was collected from the antecubital vein of
healthy adult donors with normal cell count profiles through a 19- lyzed using the Metamorph software package. A threshold was ap-
plied to all the images in a stack to distinguish platelets from thegauge needle intosyringes containing as anticoagulant the thrombin
inhibitor D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone di- background; the same value was then used in all subsequent analy-
ses of confocal images for a given experiment. The area occupiedhydrochloride (PPACK; 80 mM, final concentration). None of the
donors had taken aspirin or other drugs known to affect platelet by all thrombi in a given plane was calculated, and the volume
corresponding to a 1.0 mm thick section was estimated by multi-function in the preceding 10 days. Platelets were labeled in whole
blood by direct incubation with the fluorescent dye mepacrine (quin- plying the average area covered by platelets in two consecutive
planes by the height of the section (1.0 mm). The total volume occu-acrine dihydrochloride; 10 mM, final concentration). Although this
dye also labels leukocytes, thesecells could be readily distinguished pied by all thrombi was then estimated by summation of the sec-
tional volumes.from platelets by their relatively large size, nuclear morphology, and
sparsity; moreover, permanent leukocyte attachment to collagen
was negligible at wall shear rates above 500 s21. At a wall shear Acknowledgments
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